Altai Protocol Library New Reference: Fixed-Duration Venetoclax- Obinutuzumab for Untreated CLL U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Tucatinib with Trastuzumab and Pertuzumab for HER2-Positive Metastatic Breast Cancer U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Protocol: Neoadjuvant Endocrine Therapy with Trastuzumab and Pertuzumab for Triple-Positive Breast Cancer U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Teclistamab for Relapsed / Refractory Multiple Myeloma U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Tebentafusp for Metastatic Uveal Melanoma U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Reference: Talazoparib with Enzalutamide in HRR-Altered Metastatic Prostate Cancer U. Darda Bayraktar, MD 2026-06-15
Altai Protocol Library New Protocol: Tafasitamab – Lenalidomide with R-CHOP for High-Risk Large B Cell Lymphoma U. Darda Bayraktar, MD 2026-06-14
Altai Protocol Library New Indication: Adjuvant Selpercatinib in RET-Fusion Positive NSCLC U. Darda Bayraktar, MD 2026-06-14
Altai Protocol Library New Indication: Sunvozertinib for Untreated Advanced NSCLC with EGFR Exon 20 Insertions U. Darda Bayraktar, MD 2026-06-13
